Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLANZAPINE\SAMIDORPHAN L-MALATE for Off label use: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where OLANZAPINE\SAMIDORPHAN L-MALATE was used for Off label use.

Most Reported Side Effects for OLANZAPINE\SAMIDORPHAN L-MALATE

Side Effect Reports % Deaths Hosp.
Off label use 259 19.9% 2 14
Contraindicated product administered 86 6.6% 1 33
Dizziness 80 6.2% 0 3
Insomnia 60 4.6% 0 3
Weight decreased 59 4.5% 1 3
Weight increased 57 4.4% 0 1
Nausea 53 4.1% 0 0
Feeling abnormal 52 4.0% 0 2
Vomiting 51 3.9% 0 3
Decreased appetite 48 3.7% 0 2
Somnolence 48 3.7% 0 3
Sedation 47 3.6% 0 4
Fatigue 40 3.1% 0 2
Anxiety 37 2.8% 0 2
Drug screen false positive 36 2.8% 0 0

Other Indications for OLANZAPINE\SAMIDORPHAN L-MALATE

Product used for unknown indication (617) Bipolar disorder (167) Bipolar i disorder (165) Schizophrenia (133) Schizoaffective disorder bipolar type (31) Schizoaffective disorder (30) Psychotic disorder (26) Depression (25) Bipolar ii disorder (23) Affective disorder (18)

Other Drugs Used for Off label use

LENALIDOMIDE (5,767) ECULIZUMAB (3,550) CERTOLIZUMAB PEGOL (2,256) ABOBOTULINUMTOXINA (2,170) LEVETIRACETAM (2,161) APREMILAST (1,995) PROPRANOLOL (1,576) CETIRIZINE (1,416) HUMAN IMMUNOGLOBULIN G (1,129) THALIDOMIDE (1,033)

Related Pages

OLANZAPINE\SAMIDORPHAN L-MALATE Full Profile All Off label use Drugs OLANZAPINE\SAMIDORPHAN L-MALATE Demographics OLANZAPINE\SAMIDORPHAN L-MALATE Timeline